Search research articles
Contact Us
Filters
Showing results (51-60 of 59) with videos related to
Page
of 6
Sort By:
You have reached the last page of results.
This site can display upto 59 results.
The American Journal of Pathology
|
December 1, 1995
Role of interferon-gamma in interleukin 12-induced pathology in mice
B D Car, V M Eng, B Schnyder, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology
|
October 10, 2001
T cell involvement in cutaneous drug eruptions
Y Hari, K Frutig-Schnyder, M Hurni, et al.
Allergy
|
June 11, 2013
Desensitization in delayed drug hypersensitivity reactions -- an EAACI position paper of the Drug Allergy Interest Group
K Scherer, K Brockow, W Aberer, et al.
The Journal of Biological Chemistry
|
February 28, 1997
Tumor necrosis factor alpha enhances the expression of the interleukin (IL)-4 receptor alpha-chain on endothelial cells increasing IL-4 or IL-13-induced Stat6 activation
S M Lugli, N Feng, M H Heim, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology
|
May 30, 1998
The interleukin-4/interleukin-13 receptor of human synovial fibroblasts: overexpression of the nonsignaling interleukin-13 receptor alpha2
N Feng, S M Lugli, B Schnyder, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology
|
July 18, 2008
Toll-like receptor 4 agonists adsorbed to aluminium hydroxide adjuvant attenuate ovalbumin-specific allergic airway disease: role of MyD88 adaptor molecule and interleukin-12/interferon-gamma axis
J Bortolatto, E Borducchi, D Rodriguez, et al.
International Immunology
|
January 1, 1996
Multiple immune abnormalities in tumor necrosis factor and lymphotoxin-alpha double-deficient mice
H P Eugster, M Muller, U Karrer, et al.
Allergy
|
April 27, 2013
Skin test concentrations for systemically administered drugs -- an ENDA/EAACI Drug Allergy Interest Group position paper
K Brockow, L H Garvey, W Aberer, et al.
Allergy
|
May 5, 2016
Drug allergy passport and other documentation for patients with drug hypersensitivity - An ENDA/EAACI Drug Allergy Interest Group Position Paper
K Brockow, W Aberer, M Atanaskovic-Markovic, et al.
Page
of 6
Search research articles
Search
Showing results (51-60 of 59) with videos related to
Sort By:
Page
of 6
You have reached the last page of results.
This site can display upto 59 results.
The American Journal of Pathology
|
December 1, 1995
Role of interferon-gamma in interleukin 12-induced pathology in mice
B D Car, V M Eng, B Schnyder, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology
|
October 10, 2001
T cell involvement in cutaneous drug eruptions
Y Hari, K Frutig-Schnyder, M Hurni, et al.
Allergy
|
June 11, 2013
Desensitization in delayed drug hypersensitivity reactions -- an EAACI position paper of the Drug Allergy Interest Group
K Scherer, K Brockow, W Aberer, et al.
The Journal of Biological Chemistry
|
February 28, 1997
Tumor necrosis factor alpha enhances the expression of the interleukin (IL)-4 receptor alpha-chain on endothelial cells increasing IL-4 or IL-13-induced Stat6 activation
S M Lugli, N Feng, M H Heim, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology
|
May 30, 1998
The interleukin-4/interleukin-13 receptor of human synovial fibroblasts: overexpression of the nonsignaling interleukin-13 receptor alpha2
N Feng, S M Lugli, B Schnyder, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology
|
July 18, 2008
Toll-like receptor 4 agonists adsorbed to aluminium hydroxide adjuvant attenuate ovalbumin-specific allergic airway disease: role of MyD88 adaptor molecule and interleukin-12/interferon-gamma axis
J Bortolatto, E Borducchi, D Rodriguez, et al.
International Immunology
|
January 1, 1996
Multiple immune abnormalities in tumor necrosis factor and lymphotoxin-alpha double-deficient mice
H P Eugster, M Muller, U Karrer, et al.
Allergy
|
April 27, 2013
Skin test concentrations for systemically administered drugs -- an ENDA/EAACI Drug Allergy Interest Group position paper
K Brockow, L H Garvey, W Aberer, et al.
Allergy
|
May 5, 2016
Drug allergy passport and other documentation for patients with drug hypersensitivity - An ENDA/EAACI Drug Allergy Interest Group Position Paper
K Brockow, W Aberer, M Atanaskovic-Markovic, et al.
Page
of 6